Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-376

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 55150-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-50 mg Per Vial (Container Label)

Package Label-principal Display Panel-50 mg Per Vial (Container Label)
This is a prescription-only drug consisting of a vial containing 50mg decitabine, 68mg monobasic potassium phosphate, and 11.6mg sodium hydroxide. The recommended dosage should be checked in the package insert and carton. It is meant for intravenous infusion only and should be stored at a temperature range of 20°C to 25°C. This drug is a cytotoxic agent and the unused portions must be discarded. The vials are distributed by AuroMedics Pharma LLE and produced in India.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per Vial (Container-Carton (1 Vial))

Package Label-principal Display Panel-50 mg Per Vial (Container-Carton (1 Vial))
This is a description of Decitabine for Injection, a cytotoxic agent. The drug is supplied in a single-dose sterile vial containing 50 mg of decitabine, along with other chemicals. The drug is for intravenous infusion only, and the unused portion should be discarded. The reconstituted solution should be further diluted, and the final concentration should be 5 mg/mL with a pH of 6.7-7.3. The diluted solution must be prepared using cold infusion fluids if it is not used within 15 minutes of reconstitution. The drug is manufactured by AUROMEDICS and distributed by AuroMedics Pharma LLC. The drug should be stored at controlled room temperature. There are indications, dosage information, and precautions provided in the package insert.*
FDA Label Image

Chemical Structure (Decitabine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.